308 related articles for article (PubMed ID: 15282869)
21. Hepatitis C co-infection review.
Raymond D
Posit Aware; 2004; 15(2):28-30, 33. PubMed ID: 15106528
[No Abstract] [Full Text] [Related]
22. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
Boyle BA
AIDS Read; 2001 Aug; 11(8):387-90, 397. PubMed ID: 11570261
[No Abstract] [Full Text] [Related]
23. Management of hepatitis B in special patient populations.
Wang HS; Han SH
Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028
[TBL] [Abstract][Full Text] [Related]
24. Very few hepatitis trials recruiting.
AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
[No Abstract] [Full Text] [Related]
25. Viral hepatitis and HIV coinfection.
Sulkowski MS
J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C: who should be treated?
Campbell MS
Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):77-9. PubMed ID: 16447299
[No Abstract] [Full Text] [Related]
27. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
Corales RB; Djeloski DS; Mancenido MD; Valenti WM
AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
[No Abstract] [Full Text] [Related]
28. Hepatitis C Virus in the HIV-infected patient.
Andersson K; Chung RT
Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
[TBL] [Abstract][Full Text] [Related]
29. Therapy of hepatitis C in patients with HIV infection.
Daugherty T; Bonacini M
Expert Rev Anti Infect Ther; 2005 Jun; 3(3):375-84. PubMed ID: 15954854
[TBL] [Abstract][Full Text] [Related]
30. Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
Lê MP; Gervais A; Le Beller C; Long K; Larrouy L; Papy E; Mal H; Descamps D; Peytavin G
J Antimicrob Chemother; 2013 May; 68(5):1208-9. PubMed ID: 23335198
[No Abstract] [Full Text] [Related]
31. Hepatitis B & hepatitis C in HIV-infection.
Kottilil S; Jackson JO; Polis MA
Indian J Med Res; 2005 Apr; 121(4):424-50. PubMed ID: 15817955
[TBL] [Abstract][Full Text] [Related]
32. Viral arthritis.
Calabrese LH; Naides SJ
Infect Dis Clin North Am; 2005 Dec; 19(4):963-80, x. PubMed ID: 16297742
[TBL] [Abstract][Full Text] [Related]
33. HIV and hepatitis co-infection: a consensus for treatment?
Lumb J
Lancet Infect Dis; 2005 Apr; 5(4):202. PubMed ID: 15834972
[No Abstract] [Full Text] [Related]
34. Clinicians debate antiretroviral tactics and toxicities, resistance testing, and hepatitis virus coinfection. IAPAC sessions 2002 - May 16-17, 2002.
Mascolini M
IAPAC Mon; 2002 Jul; 8(7):190-201. PubMed ID: 12154789
[No Abstract] [Full Text] [Related]
35. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
36. HIV-1/hepatitis B coinfection.
Benhamou Y
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):229-39. PubMed ID: 15918780
[TBL] [Abstract][Full Text] [Related]
37. FDA notifications. FDA draft guidance on Hepatitis C/HIV coinfection.
AIDS Alert; 2010 Nov; 25(11):129-30. PubMed ID: 21128355
[No Abstract] [Full Text] [Related]
38. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
Bottecchia M; Garcia-Samaniego J; Soriano V
Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
[TBL] [Abstract][Full Text] [Related]
39. [When and how to treat hepatitis B and C?].
Pache I; Hess J; Gonvers JJ; Moradpour D
Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus and the liver: lessons learned and still to be learned.
Dieterich DT
Semin Liver Dis; 2003 May; 23(2):107-14. PubMed ID: 12800064
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
